BFF MDI 320/9.6 μg

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Chronic Obstructive Pulmonary Disorder

Drug Information

Target Indication

Chronic Obstructive Pulmonary Disorder

Clinical Trial

Last updated: 7/1/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

TXMD

TherapeuticsMD, Inc.

Related Pipeline

Homocystinuria

Inflammation

Hypercholesterolemia

Cardiac Surgery

Prader-Willi Syndrome

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts